€37m investment won't be the last in Cork, Robert Baffi of BioMarin says

Robert Baffi, of BioMarin, tells Pádraig Hoare that the Californian rare-disease drugs firm will invest €37m in its large site at Shanbally, in Cork, with employee numbers to hit 400 by 2020

With the tech revolution shining a light on Cork’s potential, it is easy to forget that the region is a pharma and biopharma powerhouse and is primed for further growth, if BioMarin is any barometer.